Article
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
2022-02-24
Abstract excerpt
<title>Abstract</title> <p>The recent emergence of SARS-CoV-2 Omicron variants possessing large numbers of mutations has raised concerns of decreased effectiveness of current vaccines, therapeutic monoclonal antibodies, and antiviral drugs for COVID-19 against these variants1,2. While the original Omicron lineage, BA.1, has become dominant in many countries, BA.2 has been detected in at least 67 countries and has...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b523fe62-3a8a-5316-80d9-030dbd613c39
- DOI
- 10.21203/rs.3.rs-1375091/v1
